Werewolf Therapeutics, Inc. (HOWL): Shareholders' Equity
$24.80M
As of 2025-12-31
$16.29M
As of 2026-06-30
-41.3%
3-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $24.80M | -66.2% | 2026-03-27, Balance as of period end |
| 2024-12-31 | $73.39M | -34.1% | 2026-03-27, Balance as of period end |
| 2023-12-31 | $111.37M | -9.0% | 2025-03-11, Balance as of period end |
| 2022-12-31 | $122.34M | -19.9% | 2024-03-07, Balance as of period end |
| 2021-12-31 | $152.79M | n/m | 2023-03-23, Balance as of period end |
| 2020-12-31 | -$51.86M | n/a | 2022-03-24, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Werewolf Therapeutics, Inc. (HOWL) | 2025-12-31 | $24.80M | -66.2% |
| Spero Therapeutics, Inc. (SPRO) | 2025-12-31 | $59.02M | +28.0% |
| Context Therapeutics Inc. (CNTX) | 2025-12-31 | $60.47M | -36.5% |
| Corvus Pharmaceuticals, Inc. (CRVS) | 2025-12-31 | $61.20M | +87.9% |
| Aldeyra Therapeutics, Inc. (ALDX) | 2025-12-31 | $44.25M | -37.7% |
| Grace Therapeutics, Inc. (GRCE) | 2026-03-31 | $63.90M | -4.1% |
| Incannex Healthcare Inc. (IXHL) | 2026-06-30 | $67.37M | +403.2% |
| Inovio Pharmaceuticals, Inc. (INO) | 2025-12-31 | $24.10M | -64.8% |
| Cumberland Pharmaceuticals Inc (CPIX) | 2025-12-31 | $24.88M | +8.9% |
Compare HOWL, SPRO, CNTX, CRVS side by side · Screen every company in Pharmaceutical Preparations ↗